Literature DB >> 12183325

Characterization of GABA(A) receptor ligands in the rat cortical wedge preparation: evidence for action at extrasynaptic receptors?

B Ebert1, S i Storustovu, M Mortensen, B Frølund.   

Abstract

1. GABA(A) receptor agonists have previously been characterized at human GABA(A) receptors expressed in Xenopus oocytes. The correlation between these data and functional in vivo data of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP) has shown that THIP is 100 fold more potent in clinical studies than in oocytes. 2. THIP and a series of agonists (GABA, Isoguvacine), partial agonists (Imidazole acetic acid; P4S, 4-PIOL, thio-4-PIOL) and one antagonist (SR95531) were characterized in the rat cortical wedge preparation using inhibition of spontaneous activity in Mg(++) free medium as the measurable parameter. 3. Agonists were in general 40 times more potent in the wedge preparation than at alpha(1)beta(3)gamma(2s) containing receptors expressed in Xenopus oocytes, whereas the antagonist was equipotent under these two conditions. 4. Partial agonists with responses above 6% at alpha(1)beta(3)gamma(2s) containing receptors were full agonists in the rat cortical wedge preparation, whereas partial agonists with maximum responses below 6% behaved as partial agonists in the rat cortical wedge preparation. 5. These data suggest that only a small fraction of the GABA(A) receptors in the rat cortical wedge needs to be activated by GABA(A) agonists in order to obtain a maximum response. Results therefore indicate a significant contribution of extrasynaptic receptors to pharmacological activity of exogenous applied GABA(A) agonists in this system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183325      PMCID: PMC1573472          DOI: 10.1038/sj.bjp.0704846

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Preferential coassembly of alpha4 and delta subunits of the gamma-aminobutyric acidA receptor in rat thalamus.

Authors:  C Sur; S J Farrar; J Kerby; P J Whiting; J R Atack; R M McKernan
Journal:  Mol Pharmacol       Date:  1999-07       Impact factor: 4.436

2.  Entropy as the predominant driving force of binding to human recombinant alpha(x)beta(3)gamma(2) GABA(A) receptors.

Authors:  G Maksay; R McKernan
Journal:  Eur J Pharmacol       Date:  2001-01-05       Impact factor: 4.432

3.  Allosteric modulators affect the efficacy of partial agonists for recombinant GABA(A) receptors.

Authors:  G Maksay; S A Thompson; K A Wafford
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

4.  GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain.

Authors:  S Pirker; C Schwarzer; A Wieselthaler; W Sieghart; G Sperk
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

5.  Bioisosteric determinants for subtype selectivity of ligands for heteromeric GABA(A) receptors.

Authors:  B Ebert; M Mortensen; S A Thompson; J Kehler; K A Wafford; P Krogsgaard-Larsen
Journal:  Bioorg Med Chem Lett       Date:  2001-06-18       Impact factor: 2.823

6.  Effects of GABA(A) receptor partial agonists in primary cultures of cerebellar granule neurons and cerebral cortical neurons reflect different receptor subunit compositions.

Authors:  S L Hansen; B Ebert; B Fjalland; U Kristiansen
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

7.  alpha4beta3delta GABA(A) receptors characterized by fluorescence resonance energy transfer-derived measurements of membrane potential.

Authors:  C E Adkins; G V Pillai; J Kerby; T P Bonnert; C Haldon; R M McKernan; J E Gonzalez; K Oades; P J Whiting; P B Simpson
Journal:  J Biol Chem       Date:  2001-08-08       Impact factor: 5.157

8.  Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones.

Authors:  M L Mayer; G L Westbrook; P B Guthrie
Journal:  Nature       Date:  1984 May 17-23       Impact factor: 49.962

9.  Diazepam enhances the action but not the binding of the GABA analog, THIP.

Authors:  J H Skerritt; R L Macdonald
Journal:  Brain Res       Date:  1984-04-09       Impact factor: 3.252

10.  Pharmacokinetics of the gamma-aminobutyric acid agonist THIP (Gaboxadol) following intramuscular administration to man, with observations in dog.

Authors:  S M Madsen; T Lindeburg; S Følsgård; E Jacobsen; H Sillesen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1983-11
View more
  2 in total

1.  Slow wave sleep enhancement with gaboxadol reduces daytime sleepiness during sleep restriction.

Authors:  James K Walsh; Ellen Snyder; Janine Hall; Angela C Randazzo; Kara Griffin; John Groeger; Rhody Eisenstein; Stephen D Feren; Pam Dickey; Paula K Schweitzer
Journal:  Sleep       Date:  2008-05       Impact factor: 5.849

2.  Impact of epsilon and theta subunits on pharmacological properties of alpha3beta1 GABAA receptors expressed in Xenopus oocytes.

Authors:  Martin Ranna; Saku T Sinkkonen; Tommi Möykkynen; Mikko Uusi-Oukari; Esa R Korpi
Journal:  BMC Pharmacol       Date:  2006-01-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.